filamentous actin & tracheal fusion cell, with DAAMUASp.cMa, Scer\GAL4btl.PS
filamentous actin & tracheal fusion cell, with Scer\GAL4btl.PS
filamentous actin & tracheolar cell, with Scer\GAL4btl.PS
Expression of DAAMC.Scer\UAS.P\T under the control of Scer\GAL4ey-OK107 induces very severe growth and guidance defects in the mushroom body axons Unlike in wild type, these axons fail to project anteriorly and form a huge, unstructured, randomly oriented network of projections with very prominent but misprojected bundles in the posterior region of the brain.
Expression of DAAMC.Scer\UAS.P\T pan-neuronally, under the control of Scer\GAL4elav-C155, results in severe fasciculation defects and embryonic lethality. The majority of embryos (78%) display a more prominent neuropile than observed in wild-type, commissures and nerve roots in particular appear thicker. Many axons are misrouted, and either cross the midline or exit the bundles into lateral directions.
Expression of DAAMC.Scer\UAS.P\T in the trachea, driven by Scer\GAL4btl.PS, causes distinct phenotypic effects in the fusion cells and the regular tracheal cells. In fusion cells of this genotype, there is a dramatic change in the actin organization and cuticle pattern, causing strong actin accumulation at the apical surface. The typical granular cuticle pattern is transformed towards a stripy pattern , partly resembling the taenidial folds of normal tracheal cells. Most of the actin in these cells is found in largely unorganized bundles. In tracheal cells, DAAMC.Scer\UAS.P\T overexpression results in severe impairment of taenidial fold formation and actin organization.
Coexpression of DAAMScer\UAS.P\T.cMa and DAAMC.Scer\UAS.P\T, under the control of Scer\GAL4btl.PS, causes a suppression of the Scer\GAL4btl.PS/DAAMC.Scer\UAS.P\T phenotype in regular tracheal cells but not in fusion cells.
DAAMC.UASp, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, non-enhanceable by Rac1J11
DAAMC.UASp has abnormal neuroanatomy phenotype, non-enhanceable by chic[+]/chic221
DAAMC.UASp, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, non-enhanceable by Rac1J11/Rac1J10
DAAMC.UASp, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, non-enhanceable by Rac1J11/Rac2Δ
DAAMC.UASp, Scer\GAL4elav-C155 has abnormal neuroanatomy phenotype, non-enhanceable by Rac1J11/Rac2Δ/MtlΔ
DAAMC.UASp has abnormal neuroanatomy phenotype, suppressible by ena23/ena[+]
DAAMC.UASp has abnormal neuroanatomy phenotype, suppressible by ena[+]/enaGC1
DAAMC.UASp, Scer\GAL4ey-OK107 has abnormal neuroanatomy phenotype, non-suppressible by dsh1/dsh[+]
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, non-enhanceable by Rac1J11
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ/MtlΔ
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ/MtlΔ
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ/MtlΔ
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, non-enhanceable by Rac1J11/MtlΔ
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac1J10, Scer\GAL4elav-C155
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, non-enhanceable by Rac1J11/MtlΔ/Rac1J10
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, non-enhanceable by chic[+]/chic221
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, non-enhanceable by chic[+]/chic221
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, non-enhanceable by chic[+]/chic221
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, non-enhanceable by Rac1J11
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac1J10
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, non-enhanceable by Rac1J11/Rac2Δ
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, suppressible by ena[+]/enaGC1
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, suppressible by ena[+]/enaGC1
DAAMC.UASp, Scer\GAL4elav-C155 has neuropil | embryonic stage phenotype, suppressible by ena23/ena[+]
DAAMC.UASp, Scer\GAL4elav-C155 has fascicle | embryonic stage phenotype, suppressible by ena23/ena[+]
DAAMC.UASp, Scer\GAL4elav-C155 has symmetrical commissure | embryonic stage phenotype, suppressible by ena23/ena[+]
DAAMC.UASp, Scer\GAL4btl.PS has embryonic/larval tracheal section phenotype, suppressible by Src42AE1
DAAMC.UASp, Scer\GAL4btl.PS has embryonic/larval tracheal section phenotype, suppressible by Btkk05610
DAAMC.UASp, Scer\GAL4ey-OK107 has mushroom body phenotype, non-suppressible by dsh1/dsh[+]
DAAMC.UASp, Scer\GAL4btl.PS has embryonic/larval tracheal section phenotype, non-suppressible by Rho172F
dsh1 does not suppress the growth and guidance defects seen in the mushroom body axons of flies expressing DAAMC.Scer\UAS.P\T under the control of Scer\GAL4ey-OK107.
The Scer\GAL4elav-C155/DAAMC.Scer\UAS.P\T gain-of-function phenotype (i.e the appearance of thicker commissures and nerve roots) is not affected by Rac1 gene dose (i.e. a Rac1J11/+ or Rac1J11/Rac1J10 background), a Rac1J11, Rac2Δ background or a Rac1J10, Rac2Δ, MtlΔ background.
The Scer\GAL4elav-C155/DAAMC.Scer\UAS.P\T gain-of-function phenotype (i.e the appearance of thicker commissures and nerve roots) is not affected by a chic221/+ background.
The Scer\GAL4elav-C155/DAAMC.Scer\UAS.P\T gain-of-function phenotype (i.e the appearance of thicker commissures and nerve roots) is suppressed by a ena23/+ or enaGC1/+ background.
The tracheal cuticle defects of larvae that express DAAMC.Scer\UAS.P\T under the control of Scer\GAL4btl.PS are dominantly suppressed by Src42AE1 and Btk29Ak05610. However, Rho172F does not modify the effect of modify the effect of DAAMC.Scer\UAS.P\T expression.